Search by Drug Name or NDC

    NDC 60687-0273-21 Voriconazole 200 mg/1 Details

    Voriconazole 200 mg/1

    Voriconazole is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is VORICONAZOLE.

    Product Information

    NDC 60687-0273
    Product ID 60687-273_f67b37f7-82e3-e03c-e053-2995a90ab626
    Associated GPIs 11407080000340
    GCN Sequence Number 050443
    GCN Sequence Number Description voriconazole TABLET 200 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 17498
    HICL Sequence Number 023720
    HICL Sequence Number Description VORICONAZOLE
    Brand/Generic Generic
    Proprietary Name Voriconazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Voriconazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name VORICONAZOLE
    Labeler Name American Health Packaging
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203503
    Listing Certified Through 2024-12-31

    Package

    NDC 60687-0273-21 (60687027321)

    NDC Package Code 60687-273-21
    Billing NDC 60687027321
    Package 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-273-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-273-11)
    Marketing Start Date 2017-05-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.59955
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description VORICONAZOLE 200 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis